Empaloh Tablet 10 mg (Empagliflozin)

Adult dose

The recommended dose of this medication is 10 mg once daily for monotherapy and in combination therapy with other antihyperglycemic agents such as insulin. If excellent tolerance is observed and additional blood sugar control is needed, the dose can be increased to 25 mg once daily. It can be administered without regard to meals, and the tablets should be swallowed whole. If a dose is forgotten, take it as soon as you remember, but do not take double doses in a day.

This medication should not be used by individuals who are allergic to the active ingredient or any component of this medication. This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis. Patients with severely impaired kidney function, particularly those with a glomerular filtration rate below 30 mL/min/1.73m2 or with end-stage kidney disease or on dialysis should not take this medication. This medication contains lactose, so individuals with issues breaking down lactose or genetic disorders such as galactose intolerance, Lapp lactose deficiency, and glucose-galactose malabsorption should not use it. This medication should be used cautiously in patients with slightly impaired kidney function, and kidney function should be regularly monitored, with dosage adjustments or discontinuation as necessary. In patients with heart failure, particularly those with mild to moderate severity, caution is required, and it is not recommended for those with severe heart failure. When this medication is used with drugs that can cause hypoglycemia, such as insulins or sulfonylureas, dosage adjustments may be necessary to reduce the risk of hypoglycemia. While taking this medication, keep a close watch for symptoms such as hypoglycemia, urinary tract infections, genital infections, increased urination, and decreased fluid volume since these side effects may occur. Severe metabolic abnormalities such as ketoacidosis may occur, and if symptoms like vomiting, abdominal pain, or respiratory distress are observed, consult healthcare professionals immediately. Elderly patients, especially those over 75 years of age, are at higher risk of fluid loss and should be monitored closely, while use is not recommended for those over 85 years. This medication may increase the risk of serious urinary tract infections such as urosepsis or pyelonephritis, so prompt treatment is necessary if infection symptoms occur. Pregnant women or those planning to become pregnant should avoid using this medication, and breastfeeding mothers should also discontinue breastfeeding. It is not used in children and adolescents due to lack of safety and efficacy data. No specific toxicity has been reported in cases of overdose, but appropriate treatment may be required according to clinical conditions. This medication may have a minor impact on driving or operating machinery, so caution is advised especially in cases of risk of hypoglycemia. Regularly check kidney function and blood sugar levels while taking this medication, and inform healthcare professionals if abnormalities are observed.

Serious side effects

Hives, severe swelling (angioedema), ketoacidosis, urosepsis, pyelonephritis, perineal necrosis, severe skin reactions (severe rash, blisters, skin peeling, pain in the mouth/eyes), liver abnormalities (jaundice of the skin or eyes, general malaise), severe edema (widespread swelling, markedly decreased urine output), severe neurological symptoms (intense headache, seizures, confusion, visual disturbances, paralysis), respiratory issues (shortness of breath or difficulty breathing

Mild side effects

• Hypoglycemia
• itching
• rash
• increased urination
• urinary tract infection
• vulvovaginitis
• balanitis
• increased serum creatinine
• decreased glomerular filtration rate
• thirst

This medication should be stored in a tightly closed container that protects it from air and moisture, and it is best stored at room temperature between 1 degree and 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance

Light yellow, double-convex, round film-coated tablets

Package unit

30 tablets/bottle